Skip to main content ↑ ↓
Topic: Sanofi and Regeneron present more positive data for Dupixent product (Read 64 times) previous topic - next topic

Sanofi and Regeneron present more positive data for Dupixent product

Sanofi and Regeneron present more positive data for Dupixent product

[html]PARIS (Reuters) – Healthcare co*panies Sanofi and partner Regeneron presented on Tuesday more positive data for their Dupixent product. The co*panies said…
                              

PARIS (Reuters) –     Healthcare co*panies Sanofi and partner Regeneron presented on Tuesday more positive data for their Dupixent product.


The co*panies said new data showed that Dupixent showed a significant histological remission of eosinophilic esophagitis in children 1 to 11 years old. Eosinophilic esophagitis is a chronic inflammatory disease that damages the esophagus and prevents it from working properly.



(Reporting by Sudip Kar-Gupta; Editing by Christian Schmollinger)


tagreuters.c**2022binary_LYNXMPEI9A06Y-BASEIMAGE


tagreuters.c**2022binary_LYNXMPEI9A071-BASEIMAGE

[/html]

Source: Sanofi and Regeneron present more positive data for Dupixent product (http://ht**://www.oann.c**/business/sanofi-and-regeneron-present/?utm_source=rss&utm_medium=rss&utm_campaign=sanofi-and-regeneron-present)